Treamid Therapeutics GmbH
About
Treamid is a small biotech company dedicated to developing innovative small molecules for diseases with high unmet medical need, with a particular focus on fibrotic disorders of the respiratory system. Our mission is to translate cutting-edge science into effective therapies that improve patients’ lives.
Located on Campus Berlin-Buch, Treamid operates its own in vitro laboratory and collaborates closely with leading research institutions including the Max Delbrück Center (MDC), Charité – Universitätsmedizin Berlin, and the Fraunhofer Institute. These collaborations enable us to combine strong scientific expertise with translational drug development.
Our current lead candidate is clinically ready and supported by a comprehensive preclinical efficacy and safety package. In addition to advancing our pipeline, we are actively seeking to expand our network and establish partnerships to develop new translational models and explore synergistic therapeutic opportunities.
Biomedical Research, Medicine, Human Health
Disease Area
Technology
Representatives
CEO and CSO
Treamid Therapeutics GmbH